Edwards Lifesciences Corporatio vs UnitedHealth Group Incorporated — Stock Comparison
Edwards Lifesciences Corporatio (EW) and UnitedHealth Group Incorporated (UNH) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Edwards Lifesciences Corporatio narrowly edges UnitedHealth Group Incorporated on Q·Score (7 vs 6.9 out of 10), led by Health (9.2 vs 5.8) and Quality (6.7 vs 6.2). UnitedHealth Group Incorporated scores higher on Growth, reflecting stronger revenue and earnings momentum. Analyst consensus targets imply greater upside for UNH (+17.1%) than for EW (+10.7%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.1× debt-to-equity).
⚠ earnings contracting 25% year-over-year.
81% of 26 covering analysts have a positive rating.
Analyst Consensus
Fundamentals
Frequently Asked Questions
EW vs UNH: which stock scores better overall?
Based on Q·Score, Edwards Lifesciences Corporatio (EW) scores 7/10 versus UnitedHealth Group Incorporated (UNH) at 6.9/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: EW or UNH?
UnitedHealth Group Incorporated (UNH) scores higher on Growth (7/10 vs 5.2/10). Edwards Lifesciences Corporatio reports revenue growth (13.6% YoY) while UnitedHealth Group Incorporated reports (-0.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is EW or UNH more attractively valued?
UnitedHealth Group Incorporated (UNH) scores higher on Valuation (7.8/10 vs 6.3/10). EW trades at 27.2× P/E versus UNH at 17.5×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about EW vs UNH?
There are 27 analysts covering EW with a consensus price target of $101.87, and 25 analysts covering UNH with a consensus target of $476.64. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: EW or UNH?
Edwards Lifesciences Corporatio (EW) scores higher on Quality (6.7/10 vs 6.2/10). Net profit margin: EW at 15.4%, UNH at 3.5%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: EW or UNH?
Edwards Lifesciences Corporatio (EW) scores higher on Financial Health (9.2/10 vs 5.8/10). Market beta: EW at 0.86, UNH at 0.61. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of EW and UNH?
Edwards Lifesciences Corporatio (EW) has a market capitalisation of $53.0B, while UnitedHealth Group Incorporated (UNH) has a market cap of $365.3B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do EW or UNH pay dividends?
EW does not currently pay a dividend, while UNH pays a dividend yield of 2.26%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →